| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 509.62B | 529.42B | 507.84B | 481.45B | 439.55B |
| Gross Profit | 142.79B | 150.07B | 146.41B | 249.09B | 230.16B |
| EBITDA | 140.44B | 127.81B | 141.45B | 113.59B | 102.45B |
| Net Income | 32.33B | 33.01B | 30.45B | 27.59B | 25.95B |
Balance Sheet | |||||
| Total Assets | 871.02B | 866.63B | 835.81B | 807.70B | 762.23B |
| Cash, Cash Equivalents and Short-Term Investments | 111.61B | 102.01B | 91.85B | 76.30B | 75.21B |
| Total Debt | 61.24B | 60.74B | 65.19B | 77.38B | 58.90B |
| Total Liabilities | 395.34B | 410.07B | 388.65B | 371.27B | 331.07B |
| Stockholders Equity | 461.02B | 452.39B | 442.93B | 432.09B | 428.67B |
Cash Flow | |||||
| Free Cash Flow | 52.43B | 55.00B | 47.34B | 44.92B | 52.36B |
| Operating Cash Flow | 123.68B | 145.27B | 137.51B | 136.43B | 137.53B |
| Investing Cash Flow | -96.86B | -101.29B | -95.49B | -96.80B | -80.29B |
| Financing Cash Flow | -47.00B | -42.90B | -33.48B | -40.91B | -7.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$216.63B | 10.54 | 6.09% | 5.29% | 3.54% | 5.36% | |
68 Neutral | HK$570.80B | 13.70 | 7.19% | 5.40% | 0.53% | 5.28% | |
67 Neutral | HK$1.75T | 11.87 | 10.31% | 6.00% | 1.49% | 3.06% | |
67 Neutral | HK$93.19B | 16.50 | 14.46% | 2.86% | 2.33% | 2.41% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
50 Neutral | HK$11.59B | 18.62 | 8.82% | 5.45% | 4.48% | 1820.51% | |
49 Neutral | HK$45.60B | -1,547.01 | -2.39% | 1.68% | 4.26% | 36.68% |